Unlock instant, AI-driven research and patent intelligence for your innovation.

Collagen and collagen like peptide based hydrogels, corneal implants, filler glue and uses thereof

A hydrogel and corneal technology, which can be used in medical preparations without active ingredients, medical preparations containing active ingredients, and specific peptides, etc., and can solve problems such as unknown uses.

Active Publication Date: 2019-11-22
EOSVISION MEDTECH TECH CO LTD
View PDF10 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its use in hydrogel and implant development is less well known

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Collagen and collagen like peptide based hydrogels, corneal implants, filler glue and uses thereof
  • Collagen and collagen like peptide based hydrogels, corneal implants, filler glue and uses thereof
  • Collagen and collagen like peptide based hydrogels, corneal implants, filler glue and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0133] Example 1: Collagen-like peptides

[0134] Using 36-amino acid peptide (Pro-Lys-Gly) 4 (Pro-Hyp-Gly) 4 (Asp-Hyp-Gly) 4 Collagen-like peptides were designed as a basis. Glycine and cysteine ​​were added to this polypeptide sequence to allow covalent attachment to 8-arm polyethylene glycolmaleimide (PEG) and formation of robust hydrogels. Addition of additional peptide motifs thereto renders the polypeptide multifunctional.

[0135] A Pichia template vector (pPink-aMF-COL mimic-His-P4H-HC) comprising 10 repeats of the nucleic acid sequence encoding 38-amino acid CLP was used as the template vector. The nucleic acid sequence of the template vector is represented by SEQ ID NO: 1.

[0136] Using a forward primer comprising the nucleic acid sequence shown in SEQ ID NO: 2 and a reverse primer comprising the nucleic acid sequence of SEQ ID NO: 3, one repeat of the nucleic acid encoding the 38-amino acid sequence was isolated. The nucleic acid sequence of the repeat sequen...

Embodiment 2

[0145] Example 2: Recombinant Production of Recombinant Collagen-like Peptides

[0146] The nucleic acid of Example 1 was cloned into pCOLDI expression vector (Takara Bio Inc). The vector map of the expression vector pCOLDI is as follows: figure 1 shown. The restriction sites used in this procedure were NdeI and XbaI. In addition, the forward primer and reverse primer used are represented by SEQ ID NO: 2 and SEQ ID NO: 3, respectively.

[0147] For the post-translational modification of proline residues to hydroxyproline, a pET vector comprising a nucleic acid encoding prolyl 4-hydroxylase was used.

[0148] Both expression vectors (pCOLDI and pET) were transformed into Escherichia coli BL-21(DE3) strain. Escherichia coli BL-21 (DE3) electrocompetent strain with the trade name sell. BL21(DE3) bacterial cells are used for the production of endotoxin-free recombinant proteins.

[0149] For recombinant expression of CLP, inoculate 4-20 μL of pre-cultured bacteria of ampi...

Embodiment 3

[0153] Example 3: Purification of recombinant collagen-like peptides

[0154] Collagen-like polypeptides were purified using a Ni-NTI column that specifically binds a histidine tag attached to the N-terminus of CLP.

[0155] Equilibrate the Ni-NTA column with 10-15 CV of denaturing binding buffer and apply the supernatant of the protein sample. The column was washed with 3×2 mL of denaturing binding buffer, and the protein was eluted with 5CV of denaturing elution buffer (20 mM disodium hydrogen phosphate, 0.5 M sodium chloride, 0.5 M imidazole, 8 M urea, pH 8.0). Samples were collected and analyzed using SDS PAGE. SDS-PAGE was performed on recombinant CLP using standard protocols. The results of SDS-PAGE are as follows figure 2shown. E1-E5 of the SDS PAGE results show the eluate of CLP represented by SEQ ID NO:10. His-tagged polypeptides were visualized using 300 mM imidazole.

[0156] For dialysis, collect all protein-containing eluates and combine in one 50 ml tube. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
glass transition temperatureaaaaaaaaaa
glass transition temperatureaaaaaaaaaa
Login to View More

Abstract

The present invention provides for collagen and collagen like peptide based hydrogel, corneal implants, filler glue and uses thereof. The invention represents an advancement in the field of hydrogel,corneal implants, filler glue based on collagen and collagen like peptides. The invention discloses collagen and novel collagen like peptides crosslinked with DMTMM and their use in preparation of hydrogel, corneal implant and filler glue which are highly efficacious and robust as compared to existing corneal implants. Further, the invention relates to method of treating corneal defects and diseases.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Patent Application No. 62 / 407,650, filed October 13, 2016, the entire contents of which are hereby incorporated by reference. technical field [0003] The present invention relates to collagen and modified collagen-like peptides cross-linked using DMTMM as a cross-linking agent. The present invention also relates to methods of preparing hydrogels, corneal implants and filler gels comprising collagen and collagen-like peptides cross-linked with DMTMM. Background technique [0004] The cornea is the transparent covering and main refractive part of the eye. It is responsible for transmitting light to the retina. The human cornea is composed of three main layers, an outermost epithelial layer, an intermediate stroma containing keratocytes, and an innermost monolayer of endothelial cells. [0005] One of the leading causes of blindness worldwide is corneal disease. Thes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/39A61L27/52A61L27/24A61L27/26C08J3/24
CPCA61L27/225A61L27/24A61L27/26A61L27/3834A61L27/52C08J3/24A61L2430/16A61K9/0051C07K14/78C08J3/075C08J2389/00A61K38/00A61K47/60A61K31/7088Y02A50/30C08L89/06
Inventor 梅·格里菲斯艾因·萨玛特伽各蒙汗·莱迪·加格木莱迪
Owner EOSVISION MEDTECH TECH CO LTD